ES2052583T3 - Derivados de peptidos relacionados con el gel calcitonina. - Google Patents

Derivados de peptidos relacionados con el gel calcitonina.

Info

Publication number
ES2052583T3
ES2052583T3 ES87310695T ES87310695T ES2052583T3 ES 2052583 T3 ES2052583 T3 ES 2052583T3 ES 87310695 T ES87310695 T ES 87310695T ES 87310695 T ES87310695 T ES 87310695T ES 2052583 T3 ES2052583 T3 ES 2052583T3
Authority
ES
Spain
Prior art keywords
derivatives
peptides related
serum
calcium
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87310695T
Other languages
English (en)
Inventor
Kaoru Morita
Toyonobu Uzawa
Masayuki Hori
Toshiharu Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Application granted granted Critical
Publication of ES2052583T3 publication Critical patent/ES2052583T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57527—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN PEPTIDO DE FORMULA (1), EN LA QUE Y ES AZUFRE O METILENO Y A ES ASN O ASP, O UNA DE SUS SALES FISIOLOGICAMENTE ACEPTABLES; TIENE ACTIVIDAD DE DSIMINUCION DEL CALCIO EN EL SUERO Y ACTIVIDAD DE DISMINUCION DE FOSFATO EN EL SUERO, Y POR ELLO SE PUEDE UTILIZAR EN EL TRATAMIENTO DE DESORDENES METABOLICOS DE CALCIO, ENFERMEDADES CARDIACAS Y ULCERAS POR MEJORA DEL SISTEMA CIRCULATORIO DEL CEREBRO.
ES87310695T 1986-12-04 1987-12-04 Derivados de peptidos relacionados con el gel calcitonina. Expired - Lifetime ES2052583T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28959786 1986-12-04
JP31058586 1986-12-25

Publications (1)

Publication Number Publication Date
ES2052583T3 true ES2052583T3 (es) 1994-07-16

Family

ID=26557652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87310695T Expired - Lifetime ES2052583T3 (es) 1986-12-04 1987-12-04 Derivados de peptidos relacionados con el gel calcitonina.

Country Status (4)

Country Link
US (1) US5049654A (es)
EP (1) EP0270376B1 (es)
DE (1) DE3782010T2 (es)
ES (1) ES2052583T3 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
WO1989006135A1 (en) * 1988-01-11 1989-07-13 Amylin Corporation Treatment of type 2 diabetes mellitus
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
GB8829432D0 (en) * 1988-12-15 1989-02-01 Celltech Ltd Enzymatic process
EP0408294B1 (en) * 1989-07-10 1995-09-20 Amylin Pharmaceuticals, Inc. Use of an amylin antagonist for the manufacture of amedicament for the treatment of obesity and essential hypertension and related disorders
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5567679A (en) * 1993-12-13 1996-10-22 Daly; Theodore J. Use of CGRP in treating alopecia
CN1312116C (zh) 1994-10-21 2007-04-25 Nps药物有限公司 钙受体活性化合物
DK0907631T3 (da) 1996-05-01 2003-09-22 Nps Pharma Inc Uorganiske ionreceptoraktive forbindelser
UA72460C2 (en) * 1998-04-15 2005-03-15 Aventic Pharmaceuticals Inc A process for the preparation of polymer- bound cyclic peptides
CA2292902C (en) * 1999-12-24 2012-12-18 Alain Cadieux Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
CN101120002A (zh) 2005-02-17 2008-02-06 惠氏公司 环烷基稠合的吲哚、苯并噻吩、苯并呋喃和茚衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514331A (en) * 1983-06-29 1985-04-30 University Patents, Inc. Peptide hormones with calcitonin-like activity
JPS62129297A (ja) * 1985-08-09 1987-06-11 Toyo Jozo Co Ltd カルシトニン遺伝子関連ペプチド誘導体

Also Published As

Publication number Publication date
US5049654A (en) 1991-09-17
DE3782010T2 (de) 1993-02-18
EP0270376A2 (en) 1988-06-08
EP0270376A3 (en) 1990-02-07
EP0270376B1 (en) 1992-09-30
DE3782010D1 (de) 1992-11-05

Similar Documents

Publication Publication Date Title
ES2052583T3 (es) Derivados de peptidos relacionados con el gel calcitonina.
ATE113208T1 (de) Verwendung des wirkstoffs azelastin zur bekämpfung von psoriasis-erkrankungen.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
MX9203543A (es) Medicamento.
DE69233559D1 (de) Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
DK215287A (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
DE3688038T2 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
SE8802569L (sv) Foerbaettringar vid eller avseende somatosstatiner
IT8848262A0 (it) Dispositivo di supporto laterale, in particolare per l'arco mediano del piede
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
IT8619055A0 (it) Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria.
BR9007115A (pt) Novo trombolitico
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
PT85454A (de) Verwendung von 15-deoxyspergualin als arzneimittel
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
ATA188385A (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
DE3751602D1 (de) Subkutane Verabreichung des humanen Choriongonadotropins.
NO167144C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv imidazo (4,5-f) isokinolin-2-on.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
DK301489A (da) Cgrp til anvendelse til forbedring cerebral blodtilfoersel
IT8419940A0 (it) Nuovi medicinali per il trattamento di malattie cardiache.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 270376

Country of ref document: ES